Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies

BACKGROUND: Convalescent plasma is one of the treatment options for COVID-19 which is currently being investigated in many clinical trials. Understanding of donor and product characteristics is important for optimization of convalescent plasma. METHODS: Patients who had recovered from CO­VID-19 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Körper, Sixten, Jahrsdörfer, Bernd, Corman, Victor M., Pilch, Jan, Wuchter, Patrick, Blasczyk, Rainer, Müller, Rebecca, Tonn, Torsten, Bakchoul, Tamam, Schäfer, Richard, Juhl, David, Schwarz, Tatjana, Gödecke, Nina, Burkhardt, Thomas, Schmidt, Michael, Appl, Thomas, Eichler, Hermann, Klüter, Harald, Drosten, Christian, Seifried, Erhard, Schrezenmeier, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger GmbH 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216018/
https://www.ncbi.nlm.nih.gov/pubmed/34177417
http://dx.doi.org/10.1159/000515610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216018/
https://www.ncbi.nlm.nih.gov/pubmed/34177417
http://dx.doi.org/10.1159/000515610

Ejemplares similares